Relates to the continuation of the empire state stem cell board; makes such provisions of law permanent.
This bill would make permanent the statutory framework for the Empire State Stem Cell Board and the related Empire State Stem Cell Trust Fund. It amends the Public Health Law and related provisions to remove the existing sunset language that would otherwise end the board’s authority, including the prior prohibition on making grants after April 1, 2021 and the scheduled repeal date of December 31, 2025. The bill also revives and continues the affected provisions so they remain in force as of December 30, 2025.
Substantively, the bill preserves the board’s authority to administer the trust fund and award grants for basic, applied, translational, and other research and development activities that advance stem cell biology. It keeps in place the board structure, including the funding and ethics committees chaired by the commissioner, and maintains the legal basis for state support of stem cell research. The measure is framed as a continuation and permanence bill rather than a policy expansion, meaning it sustains an existing state research program instead of creating a new one.
The bill would amend the Public Health Law, the State Finance Law, and related provisions of chapter 58 of the laws of 2007 to eliminate the sunset and make the Empire State Stem Cell Board and its funding authority permanent. As a result, the state would continue to have a legal mechanism for administering the stem cell trust fund and issuing grants for stem cell research beyond the prior expiration date. Researchers, institutions, and other grant recipients eligible under the program would remain able to seek funding under the existing statutory structure.
The available context suggests generally supportive or noncontroversial treatment of the bill, with no recorded committee transcript objections or recorded votes in the provided materials. The bill’s caption and text indicate a straightforward continuation of an established research program, which typically signals legislative intent to preserve an existing state investment rather than debate a new policy direction. Because no opposition or amendments are shown in the supplied record, the overall sentiment appears favorable or at least procedural.
The main point of potential contention is the decision to make the stem cell board permanent rather than allowing the program to expire or be reauthorized periodically. Any debate would likely center on the continued use of state resources for stem cell research, the role of government in funding biomedical research, and oversight through the board’s ethics and funding committees. However, the provided materials do not show active disagreement, named opponents, or specific objections.